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Abstract: Candida albicans is an ubiquitous fungal commensal of human skin and 
mucosal surfaces, and at the same time a major life-threatening human fungal pathogen in 
immunocompromised individuals. Host defense mechanisms rely on the capacity of 
professional phagocytes to recognize Candida cell wall antigens. During the past decade, 
the host immune response to Candida was dissected in depth, highlighting the essential 
role of C-type lectin receptors, especially regarding the power of the Dectins’ family in 
discriminating between the tolerated yeast-like form of Candida and its invading 
counterpart, the hyphae. This review focuses on the immuno-modulatory properties of the 
Candida morphologies and their specific interactions with the host innate immune system 
in different body surfaces. 
Keywords: Candida albicans; innate immunity; morphology; C-type lectin receptors; 
pathogen; yeast-hyphae 
 
  
OPEN ACCESS
Pathogens 2015, 4 640 
 
1. Introduction 
Pathogens are usually regarded as autonomous causative agents in virulence studies even though the 
host and the host microbiota can influence their pathogenicity [1]. In healthy individuals, most of the 
microbial resident eukaryotes are rather mutualistic or commensal and do not cause infections. 
However, when the host microbiota gets disturbed or the host defense mechanisms extenuated these 
commensals can become pathogens [2]. An important representative of such opportunistic fungi is the 
yeast C. albicans, a permanent member of the human microbiota, present on the skin [3], oral cavity 
[4], vagina [5,6] and gut mucosa [7] in 30%–70% of healthy individuals. Under normal conditions,  
C. albicans does not cause significant disease [8,9], yet, it has the potential to infect and colonize the 
host in immunocompromised individuals, like HIV-patients [10], lung transplant recipients [11] and 
cystic fibrosis patients [12]. Invasive Candida infections lead to high mortality and to enormous 
treatment costs of annually US$ 8 billion alone for the United States [13]. 
Generally, the interaction between the human host and its microbiota is based on the immunological 
tolerance of colonizing microorganisms by the mucosal host defenses. This commensal stage is 
regarded to be inoffensive to the host due to a tight control that is highly regulated by a continuous or 
transient cross-talk between the fungus and the host immune system [14]. The latter maintains 
homeostasis with the resident mycobiota, ensuring the balance between tolerogenic and pro-
inflammatory response. In parallel, disturbance of the network of competitive commensal bacteria can 
lead to increased susceptibility to C. albicans infections and distorted immunological responses against 
C. albicans have been proposed to contribute to the pathological auto-inflammation that occurs in 
patients with Crohn’s disease [15]. 
Candida is a dimorphic fungus with distinct phenotypical features in its yeast form versus its hyphal 
form. This phenotypic transition led to a long-lasting debate on relative attributes of C. albicans 
morphotypes during the colonization of skin and mucosae, and subsequently on the invasion of the 
bloodstream and deep tissues [16,17]. Whereas disseminated candidiasis is generally induced by the 
yeast form, mucosal diseases are more strongly correlated to filamentous forms like invasive hyphae 
and pseudohyphae [18]. The Candida cell wall is mainly composed of different carbohydrate moieties, 
such as β-glucan, mannan and chitin (Figure 1). In the course of a C. albicans infection the initial 
response of the innate immune system is determined by the recognition of these fungal cell wall 
components, also referred as pathogen associated molecular patterns (PAMPs), by pattern recognition 
receptors (PRRs) located on the surface of innate immune cells. C-type lectin receptors (CLRs) are the 
main group of PRRs involved in antifungal responses, recognizing polysaccharide structures of 
microorganisms [19]. Individual CLRs, particularly receptors of the “Dectin-1” and “Dectin-2” 
families [20], are able to recognize different fungal pathogens but there is a clear overlap in the 
substrate recognized by some of these receptors [19,21–23]. 
Differences in TLR and CLR signaling can be used to classify microorganisms for the induction of 
pro-inflammatory or tolerogenic signals [24,25]. This fine-tuned recognition potential opens the 
possibility to investigate in depth the human susceptibility to fungal infections caused by specific 
strains. Thus, discovering differences and commonalities allows the subsequent development of new 
antifungal therapies. 
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Figure 1. Candida albicans morphotypes and cell wall composition. (A) The various 
morphologies of C. albicans play different roles in colonization and disease. White yeast 
cells are important for establishment and dissemination of fungal infections, and 
pseudohyphae and true hyphae for tissue penetration and invasion. Opaque-phase cells are 
mating competent cells that resemble gastrointestinally induced transition (GUT) cells, but 
other than opaque cells they lack surface pimples in their cell wall and have been uniquely 
adapted for commensal growth; (B) Schematic diagram of the cell wall composition in C. 
albicans yeast cells and hyphae. In yeast and hyphal forms the sugar moieties present on 
the fungal cell wall are the same but their exposure and thickness determine different 
immunogenic properties. For example, β-glucans are just exposed on the yeasts’ bud scars 
and division septa and are hidden by a surface layer of mannan in the hyphal form. 
In this review, we will describe the most recent discoveries on the immuno-modulatory properties 
of C. albicans morphotypes relevant to the interaction with the host, and the immunological 
consequences of the underlying shifting nature of the cell surface of this fungus. We will further focus 
on new advancements regarding the important role of the Dectin-1 and Dectin-2 receptor families in 
terms of antifungal mucosal immunity in different body districts (Figure 2). 
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Figure 2. C. albicans and mucosal immunity. The major cells participating in the Dectin-1 
mediated antifungal immune response are depicted for four body sites frequently subjected 
to Candida infections. (A) Skin: On the epidermis Candida is mainly present as yeast-like 
cells while pseudohyphae are the predominant form in the dermis. The epidermis is 
interspersed with LCs, DETCs and CD8+ T cells, representing the first line of defense 
towards yeast-like cells. To face hyphal invasion, the dermis contains CD4+ T effector 
memory cells, macrophages, mast cells and DCs; (B) Oral cavity: DCs and LCs reside in 
the stratified squamous epithelium. In the lamina propria, DCs project dendrites into the 
epithelium to uptake antigens and to prime CD4+ T cells; (C) Vagina: In healthy 
individuals Lactobacillus species produce a low pH which keeps pathogens at bay. The 
vaginal mucosa is surveyed by macrophages and DCs present in the epithelial layer (LCs, 
CD8+) and the submucosal lamina propria (CD4+); (D) Gut: In the gut lumen C. albicans 
is predominately present in small numbers and as yeast-like cells which do not cause 
epithelial damage. Contrary high loads of Candida lead to abundant growth on the surface 
and the mucosa is invaded by the hyphal form. CD103+ DCs, macrophages and NK cells 
collaborate in promoting the activation of the appropriate Th response. Mϕ, macrophage; 
DC, dendritic cell (prefix “O” oral, “V” vaginal); LC, Langerhans cell; DETC, dendritic 
epidermal T cells; NK, natural killer cell; CD, cluster of differentiation. 
2. The Highly Plastic Nature of C. albicans Morphology and Its Implications for Pathogenicity 
As indicated, C. albicans uptake and clearance require a concert action of different receptors of the 
host innate immune system which is responsible for the recognition of PAMPs and for the subsequent 
release of an antifungal-specific immune response. C. albicans developed an enormous phenotypic 
armamentarium to colonize diverse host niches and to escape the host immune defense. A key 
virulence factor of C. albicans pathogenesis is its ability to switch between different morphologies, 
comprising yeast, pseudohyphae and true hyphae (Figure 1). C. albicans uses the reversible transition 
Pathogens 2015, 4 643 
 
to filamentous growth as a response to environmental cues and to either block or avoid recognition by 
stimulatory PRRs [26]. 
The current paradigm is that yeast forms are critical for colonization, early infection and 
dissemination, while filaments are responsible for tissue invasion and deep infection [26,27]. These 
morphological transitions go along with cell wall remodeling, leading to a change in the composition 
of the exposed components, which in turn influences the recognition by the host immune system. The 
fungal cell wall consists of two main parts: an inner skeleton composed of β-glucan and chitin and an 
outer cell surface layer of mannan (Figure 1). Cell wall carbohydrates represent the major PAMPs of 
Candida and their different exposure on the surface is thought to influence the recognition by 
leukocytes. Here, mannan, as the outermost layer, masks the subjacent cell wall layers and thus, 
prevents the Dectin-1 pro-inflammatory response [28,29], yet on the bud scars chitin and β-glucan can 
become exposed to the surface [30,31]. 
Despite this findings, recent analyses of the interaction between murine macrophages and  
C. albicans mutants defective in filamentation suggest that rather than filamentation, the change in the 
cell wall composition, that occurs during the yeast-to-hyphae transition, is the driving force for 
infection causing macrophage lysis and Candida outgrowth [32]. Here, a genome scale analysis 
revealed 102 negative and 872 positive genetic regulators during C. albicans morphogenesis 
highlighting the importance of the early and middle stages of ergosterol biosynthesis during adaption or 
evasion of the immune system [32]. 
Further, macrophage migration towards C. albicans has been shown to depend on the glycosylation 
status of the fungal cell wall, but not on cell viability or morphogenic switching from yeast to hyphae. 
Lacking specific PAMPs, C. albicans glycosylation mutants are slowly phagocyted by macrophages 
and in particular mannosylation seems to be a key determinant in the rate of macrophage engulfment, 
consequent fungal recognition and clearance through differential activation of macrophage PRRs [33]. 
Additionally, apart from protection against the host defense by camouflaging cell wall 
polysaccharides against detection of the innate immune system, covalently linked cell wall proteins 
(CWPs) serve several important virulence features such as adhesion, biofilm formation and tissue 
invasion. The diversity of CWPs is amplified by another particularity of Candida species: the 
ambiguous translation of the serine CUG codon as serine and leucine [34,35]. Here, especially CWPs 
are enriched in CUG codons and it was shown that increased CUG mistranslation is an important 
factor in triggering the above mentioned virulence attributes by creating variability in CWPs [35,36]. 
These studies on codon ambiguity open a new perspective on the immune-modulatory capacities of 
Candida by expanding its adaptation to host microniches [35,36]. 
Another fascinating transition is the mating-type locus (MTL) controlled white-opaque switch from 
the yeast morphology to the mating-competent elongated cell morphology with pimpled cell  
walls [37]. This switch is a phenotypic transition associated with changes in cell morphology, 
physiology and gene expression [38] and is accompanied by differences in virulence. In mouse models 
the smooth white cells have been shown to colonize mouse kidneys rapidly and at higher levels than 
the hyphae-like opaque cells, while the latter have advantages in the colonization of the skin [38]. 
Recently two new cell types, gray and GUT (gastrointestinally induced transition), were added to the 
C. albicans phenotypic switching system [39,40]. GUT cells resemble opaque cells but lack pimples 
on their cell surface. They seem to be optimized for commensalism in the mammalian digestive tract 
Pathogens 2015, 4 644 
 
[40]. Gray cells are also elongated but smaller than opaque and GUT cells and colonies have a smooth 
gray colored appearance [39]. Both cell types showed higher expression of secreted enzymes and cell-
wall remodeling proteins when compared to white and opaque cells. Interestingly, gray cells had an 
advantage over white cells regarding dissemination in an ex vivo tongue infection model and caused 
more damage in an in vivo skin infection model [39]. 
Further, C. albicans forms biofilms which represent a mixture of yeast and filamentous cells, but 
also in this regard C. albicans is unique as it forms two types of biofilms, one pathogenic and one  
sexual [41]. Like for white-opaque switching the form of the biofilm depends on the MTL 
conformation. Ninety percent of strains exhibit the a/alpha MTL configuration forming the pathogenic 
biofilm that is robust, impermeable and drug-resistant, while homozygosity of the MTL leads to a 
drug-susceptible biofilm that is associated to mating [41]. Biofilm formation starts with the adherence 
of yeast-form cells to the substrate but the formation of “sticky” hyphae is regarded as the initiation 
step of biofilms [42]. For dispersal the yeast to hyphae transition seems to be reversed as mature 
biofilms release yeast-form cells and this dispersed cells exhibit an increased potential for adherence 
and filamentation. Therefore, C. albicans biofilms in implanted medical devices are a main source of 
disseminated infection leading to high mortality [42]. 
Taken together this complex plasticity and strong remodeling ability together with the discovery of 
novel cell types enable a specific capability of C. albicans to alternatively mask or uncover  
immune-stimulatory antigens, and thus, provides an incredible complexity of host—fungal interactions. 
3. C-Type Lectins in Fungal Immunity: Dectin-1 and Dectin-2 Signaling 
CLRs receptors play a major role in anti-fungal immunity, both in mice and men [43].  
Receptor-mediated responses include fungal binding and phagocytosis, as well as production of 
soluble molecules, including cytokines, chemokines and inflammatory lipids, which drive 
inflammation and adaptive immunity in the host. These actions are dependent on the activation of a 
common signaling pathway that involves Syk kinase, Card9 and NF-κB in both DC and macrophages 
[44] and that directly modulate adaptive immunity by priming Th1 and Th17 responses [19–22] 
(Figure 3). Indeed, defects in several components of the Th17 pathway, ranging from the signaling 
molecules (CARD9, STAT1, STAT3) to the cytokines involved (IL-17), have been linked to chronic 
mucocutaneous candidiasis [23,45]. All of these responses are mainly driven by the Dectin-1 and Dectin-
2 receptors [43]. 
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Figure 3. Schematic representation of selected signal networks induced by Dectin-1 and 
Dectin-2. Dectin-1 and Dectin-2 induce intracellular signaling via tyrosine (Y)-based 
activation motifs (immunoreceptor tyrosine-based activation motifs or ITAMs) which 
recruit and activate Syk-kinase either directly, or indirectly through the FcγR adaptor 
chain. Signaling through protein-kinase C (PKC) δ activates the Card9-Bcl10-Malt1 
complex and induces gene transcription and the production of various inflammatory 
mediators. Dectin-1 can signal via the Raf-1 kinase pathway which modulates other 
signaling pathways, including those induced by the Toll-like receptors (TLR) and the 
Dectin-1/Syk pathway. Dectins can also collaborate with TLRs, to synergistically induce or 
repress various cytokines and chemokines and to mediate fungal phagocytosis (not shown). 
Dectins-mediated recognition of C. albicans yeasts or hyphae drives their uptake and 
killing by phagocytes, and directs the development of protective Th1/Th17 responses. 
Induction of IL-12 drives IFN-γ production by Th1 cells, which is critically required for 
the activation of phagocytes. Signals inducing IL-10 production lead to Treg 
differentiation. On the other hand, induction of IL-1β, IL-6, and IL-23 promotes Th17 
differentiation, which drives the production of IL-17 and IL-22. 
3.1. Dectin-1 
Dectin-1 signaling is considered archetypal for non-Toll like pattern recognition receptor mediated 
signal transduction. It was first identified on DCs [46] but later it was shown that the receptor is also 
widely expressed on other cell types like macrophages, neutrophils (Robinson, et al., 2006, Taylor,  
et al., 2002), γδ T cells, and on epithelial cells of the mucosa (Martin, et al., 2009, Rand, et al., 2010). 
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Dectin-1 recognizes β-1,3-glucans in a calcium-independent manner, and is involved in both ligand 
uptake and phagocytosis, as well as proinflammatory cytokine production. 
Through its pathway, Dectin-1 can synergistically collaborate with the TLRs to induce  
pro-inflammatory responses (Brown, 2006) but also without TLR engagement it can elicit a robust 
inflammatory response in DCs [19]. This response is modulated by the progression of the phagocytosis 
following Dectin-1 clustering into “phagocytic synapses” (also known as phagocytic cups) [47], 
resulting in a dramatically augmented inflammatory response which is mainly induced by β-glucan 
through a mechanism previously referred as “frustrated phagocytosis” [48,49]. Frustrated phagocytosis 
indicates for example the limit of phagocytes to internalize just as many particles that they burst [50]. 
Similar to other CLRs, Dectin-1 engagement leads to tyrosine phosphorylation of the  
ITAM-like/ITAM motifs, recruitment and activation of Syk kinase and subsequent activation of the 
CARD9–Bcl10–Malt1 complex through PKCδ [51,52] (Figure 3). Stimulation of this pathway by 
Dectin-1 and other Syk-independent pathways, as those mediated by Raf-1, results in the activation of 
several transcription factors including canonical and non-canonical subunits of NF-κB as well as 
NFAT, IRF1 [53–55] and IRF5 [56]. A recent study in mice showed that, Dectin-1 activation of 
CARD9 recruits and activates HRas through Ras-GRF1 phosphorylation resulting in the induction of 
ERK-mediated signaling in bone-marrow derived macrophages and DCs [57]. This CARD9 activation 
lead to an increased survival of mice during systemic candidiasis [57]. 
In general, Dectin-1 signaling regulates numerous cellular responses like phagocytosis, autophagy 
and the respiratory burst as well as, the production of inflammatory lipids, cytokines and chemokines 
such as the Th17- polarizing cytokines IL-23, IL-6 and IL-1β. Especially, Dectin-1 induced production 
of IL-1β is of interest, as it involves both the NLRP3/caspase-1 and non-canonical caspase-8 
inflammasomes [54,58,59]. 
While it is generally accepted that Dectin-1 is able to induce Th17 responses [19] and instruct Treg 
to express IL-17 [60] in vitro, it is controversial whether Dectin-1 promotes these responses during a 
fungal infection. For example in mice Dectin-1 is not required for IL-17 production during a  
gastro-intestinal infection with C. albicans [61] but human deficiencies in Dectin-1 result in 
diminished Th17 responses and increased susceptibility to mucosal candidiasis [45]. This discrepancy 
reflects once more the existing differences among mice and men. Further, studies demonstrated that 
Dectin-1 recognition clearly depends on the fungal strains [62] and on the accessibility of the ligand on 
the fungal cell wall [63]. 
3.2. Dectin-2 
An efficient antifungal immunity requires also Dectin-2, whose importance in protective anti-fungal 
immunity has been deeply investigated in mice [64,65]. While Dectin-1 recognizes the yeast fungal 
form, soluble Dectin-2 seems infact to preferentially bind the hyphal form of C. albicans [66], 
recognizing cell wall α-mannans [22]. Initially, Dectin-2 was identified as a Langerhans cell-specific 
receptor, but subsequently it was shown to be expressed on a variety of myeloid cells, including tissue 
macrophages, neutrophils and several DC subsets (e.g., pDCs) [20,67–70]. Dectin-2 shows a divergent 
expression pattern between humans and mice. In humans Dectin-2 [71,72] transcripts were detected in 
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lung, spleen, lymph nodes, leukocytes, bone marrow and tonsils, but unlike in mice, Dectin-2 was not 
expressed in the human thymus. 
While Dectin-1 forms a homodimer after engagement, Dectin-2 is associated to FcRγ [66]. Similar 
to Dectin-1, signaling from Dectin-2 passes through the Syk, PKCδ and CARD9–Bcl10–Malt1 
pathway, leading to the induction of several cytokines and chemokines (including TNFα, IL-2, IL-10, 
IL-23, IL-1β, IL-6 and IL-12) [20,22,53,66,73] (Figure 3). Further in mice, Dectin-2 signaling has 
been shown to involve phospholipase Cγ2 (PLCγ2) and mitogen-activated protein kinases [74]. Here, 
in vitro experiments could unveil that, following fungal challenge, abrogating PLCγ2 results in the 
defective activation of NF-κB and MAPK and a significantly reduced production of reactive oxygen 
species. In addition, PLCγ2-deficient mice are defective in clearing C. albicans systemic infection in 
vivo [74]. Indeed, mice lacking Dectin-2 demonstrated greatly increased fungal susceptibility, with 
consequent increased fungal burden and death [22]. Abolishing Dectin-2 results in impaired cytokine 
response impacting the ability of the DCs to prime Th1/Th17 differentiation in response to Candida 
intraperitoneal infection [20,22]. Further, Dectin-2 promotes Th17-biased immunity in response to 
fungi through the differential activation of cRel containing NF-κB dimers by Malt1, and the 
preferential induction of IL-23 and IL-1β [75]. 
As observed for Dectin-1, triggering of the Dectin-2-Syk signaling induces the respiratory burst, 
fungal killing by ROS production [76] and NLRP3 inflammasome activation [77]. During C. albicans 
infection, Dectin-1 and Dectin-2 synergistically cooperate to cope with the invading fungus. Robinson 
et al. (2009) used a blocking mAb against Dectin-2 to treat murine wild-type and Dectin-1-deficient 
DCs. Stimulation of these DCs with heat-killed C. albicans or zymosan revealed an almost complete 
abolition of cytokine production when both of these CLRs were knocked out [20]. This result was 
reminiscent of those observed with Syk-deficient cells and therefore it has been proposed that all  
Syk-dependent responses to Candida may depend on Dectin-1 and Dectin-2. However, Th17 responses 
were only dependent on Dectin-2, and not Dectin-1, suggesting that Dectin-2 is the main receptor 
during C. albicans systemic infection [20]. 
3.3. Dectin-3 
Several other microbial antigens contribute in sensing C. albicans [78–82,83]. Among those, 
Mincle, DCIR, BDCA2 and Dectin-3 (previously named CLECSF8 or Clec4d) have been shown to 
share structure and signaling features with Dectin-2, and therefore included in the Dectin-2 family [84–
86]. Dectin-3 is expressed in peritoneal macrophages, in the spleen and bone marrow and only at lower 
level in lymph nodes and lungs [87]. Blocking or deficiency of Dectin-3 rendered mice more 
susceptible to Candida systemic infection [88] and Dectin-3 seems to have redundant functions with 
Dectin-2. Like Dectin-2 it is able to specifically recognize α-mannans that are exposed on the surface 
of C. albicans hyphae [88] and Dectin-3 stimulation by these hyphae effectively activates p65 nuclear 
translocation, Syk phosphorylation and Ikα degradation. Here, Syk inhibition completely blocks p65 
nuclear translocation, assuming that Dectin-3 induces Syk-dependent activation of NF-κB [88]. This 
discovery could explain why murine cytokine production induced by C. albicans hyphae is only 
partially dependent on Dectin-2 [22]. In this regard, it is notable that a recent study demonstrated that 
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Dectin-2 and Dectin-3 can form a heterodimeric PRR with increased sensitivities for recognizing 
surface mannose-rich structures [88]. 
3.4. Dectin-1 Antagonist: CLRs Antagonism 
As shown above, some PRRs demonstrate some degree of redundancy in certain roles, which are 
not only restricted to CLRs. A well-known example of convergence and cooperation in activation of 
inflammatory gene expression is the integration between Dectin-1 and TLR2-mediated signaling. This 
synergism is dependent on Syk and is most pronounced during NF-κB activation [89]. It leads to a 
consequent production of Th17 priming cytokines like TNFα, IL-6, IL-23 [89] and IL-1β [59], but 
simultaneously to down-regulation of IL-12p70 [89]. This is coherent with the discovery that IL-12p70 
is the target of Mincle suppression [55]. It has been recently shown that while Dectin-1 and Dectin-2 
trigger the Syk-CARD9-MALT1-BCL10 module to activate NF-κB, Mincle uses the same signaling to 
induce a PI3K-PKB activation without NF-κB activation. The simultaneous activation of Dectin-1 and 
Mincle leads to DC induction of IL-6, IL-23, IL-1β but not IL-12p70. Mincle activates a secondary 
signaling through PI3K-PKB that directed Mdm2-mediated proteosomal degradation of IRF1. IRF1 
degradation and subsequent selective abrogation of IL-12p35 transcription promote a shift from a Th1 
antifungal response towards Th2 differentiation [55]. This shift probably contributes to the 
establishment of fungal infections, and thus, presents a strategy by which fungal pathogens exploit 
selective PRRs to evade and promote their survival. 
4. The Mucosal and Epithelial Barrier and C. albicans 
C. albicans is able to colonize the healthy oral, vaginal and gastro-intestinal mucosa and the skin. 
Here, immune defensive mechanisms allow colonization by Candida but prevent its dissemination and 
invasion, unless the epithelial barrier is breached or the immune system compromised. Indeed an 
equilibrium exists that balances the defense response against invading tissue. Moyes et al. [90] attempt 
to understand how epithelial cells, the cell type in closest contact with mucosal or skin flora, are able 
to distinguish between colonizing C. albicans that poses no apparent threat and the invading Candida 
that can result in mucosal or systemic infection. The authors proposed that a common core of 
recognition leads to the early activation of NF-κB and the MAPK c-Jun through p38 in a morphology 
independent manner. After this initial recognition hyphal formation and fungal burden can elicit a 
second signaling through MAPK, MKP1, and c-FOS which consequently induces a strong pro-
inflammatory response. Thus, fungal germination and the recognition of hyphae by the epithelial cell 
represent a major danger signal upon tissue invasion. Nowadays a paucity of data exists on the role of 
receptors and signaling integration that enable the host immune system to discriminate between 
colonizing and invading Candida, revealing that Dectin-1 and Dectin-2 seem to be differently involved 
in different mucosal sites. 
4.1. Skin 
Mucocutaneous immunity to C. albicans requires Th17 differentiation that in vitro is activated upon 
hyphae recognition. On the skin stratum corneum, C. albicans exists as yeast form, while in the dermis 
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and internal organs it is predominantly present as pathogenic pseudo-hyphae [91]. During epicutaneous 
infection, CD103+ dermal DCs prime Th1 differentiation through IL-12 secretion [92]. Langerhans 
cells (LCs) on the other hand are fundamental for Th17 differentiation via IL-1β, TGFβ and IL-6  
production [93]. Of consequence, several subsets of DCs could be potentially engaged to properly 
respond to the various morphotypes. Using a skin infection mouse model, it has recently been shown 
that C. albicans yeasts but not pseudo-hyphae were able to induce Th17 adaptive responses.  
This activation relies on Dectin-1 triggering on LCs and subsequent IL-6 production. Nevertheless, 
pseudohyphae, that after spreading and invasion are the predominant form on the skin, failed to 
activate Dectin-1 competent CD11b+ dermal DCs [94]. This defect could be rescued by addition of 
exogenous Dectin-1 ligand, indicating that, during the epicutaneous challenge, dermal DCs have 
limited access to antigens due to Candida morphological switch [94]. The same authors found that 
Th17 provided protection against cutaneous but not systemic infection, while Th1 provided the 
opposite [94]. 
Innate immune cells with phagocytic activity such as neutrophils, macrophages and mast cells are 
the first defense line on the skin. Mast cells for example can degranulate in response to C. albicans and 
kill them [95] before they induce chemokines and cytokines release to recruit other immune effector 
cells [96]. Mast cells are equipped with a vast array of PRRs, including Dectin-1, whose role in 
mediating their response to C. albicans has been recently addressed [97]. It is now clear that mast cells 
are able to recognize both the hyphal and the yeast form, by inducing Syk phosphorylation and NF-κB 
activation through IKBα degradation. Phagocytosis and ROS production were associated with TNFα, 
IL-6, IL-10, CCL3 and CCL4. However, just the yeast form was able to induce IL-1β, through NLRP3 
inflammasome activation [97]. NLRP3 plays an essential role in host defence during in vivo infection with 
C. albicans [59]. Moreover, the switch from yeast to hyphae is necessary for NLRP3 activation and IL-
1β secretion in macrophages, and it was suggested that the NLRP3 inflammasome is activated by the 
membrane disruption that occurs during this transition, rather than by the hyphae themselves [98]. This 
specific morphotype activation reveals once more the fundamental role of the morphological transition 
for C. albicans’ adaptation to the host. 
4.2. Mouth 
Candidosis is the most common oral opportunistic infection [99,100]. Symptomatic oral infection 
with C. albicans is characterized by invasion of the oral epithelium by virulent hyphae. In response to 
them, myeloid DCs in the oral mucosal epithelium activate different receptors including TLR2, Dectin-1 
and Dectin-2. Their individual or combined activation by C. albicans hyphae, triggers intracellular 
signaling pathways including the NF-κB, the MAPK and the IRF pathways [90,101]. Like on other 
mucosa, C. albicans-induced activation of the Dectin-1 receptor-Syk-CARD9 intracellular signaling [19] 
and co-stimulation of Dectin-1 and Dectin-2 pathways [75] promote DCs maturation and secretion of 
IL-23 and IL-β, and thus consequently boosts the differentiation of Th17 cells. This adaptive response, 
rather than the Th1 response, appears essential in limiting the oral candidiasis infection in both human [99] 
and mice [100]. In humans, deficiency in CARD9, the central signaling molecule downstream of 
CLRs, determines susceptibility to chronic mucocutaneous candidiasis due to a lack of Th17 response 
induction [102]. In mice, it has been observed that CARD9 is required for the adaptive C. albicans 
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response but not necessarily for effective oral mucosal innate protection carried out by IL-17 
producing innate cells [103]. This discrepancy in innate and adaptive immune activation by  
CLR-mediated signaling could indicate how the immune system evolved to specifically respond to the 
infection requirements. 
4.3. Gut 
Fungi and particularly C. albicans are important components of the gut microbiota. In the gut, fungi 
are recognized by Dectin-1. Its absence seems to increase susceptibility to murine experimental colitis, 
leading to an increase in Candida colonization, and in parallel in humans a severe form of ulcerative 
colitis is strongly linked to a polymorphism in the gene for Dectin-1 (CLEC7A) [104]. 
Along the gastrointestinal tract from the ileum to the colon Dectin-1 has been shown to be 
expressed not only on the surface of immune cells but also on intestinal epithelial cells (IEC) [105]. Its 
expression was found similar to that presented by lamina propria CD45+ CD13+ macrophages. IEC 
activation by β-glucan leads to a Dectin-1-dependent Syk phosphorylation and cytokine chemokine 
production, resulting in high levels of IL-8 and CCL2 [105]. This recent discovery proposes that IEC 
could act in concert with DCs and resident macrophages in mucosal recognition and immunity to C. 
albicans. Moreover, other PRR signaling might induce Syk phosphorylation in vivo [106,107], thus the 
involvement of Dectin-2, Dectin-3 and Mincle cannot be excluded in IEC driven fungal immunity. 
In susceptible hosts systemic C. albicans infections are thought to start in the gastro-intestinal tract. 
As hyphal forms predominate at sites of primary epithelial infection [90], morphogenetic shift back to 
yeast cells seems to facilitate the access of C. albicans to the bloodstream and their consequent 
systemic spread [91]. To test this hypothesis of GI colonization immunocompetent mice were treated 
with antibiotics and led to be colonized by hyphae or yeasts of C. albicans. The results showed that the 
yeast form was favored in the GI tract while the filamentous form was rapidly cleared [108]. In 
contrast, for tissue invasion Vautier et al [108] discovered that the ability to transition between 
morphotypes is essential for GI survival in conditional mouse mutants. This is in agreement with the 
discovery of the yeast-like GUT morphotype, present after gut colonization [40]. During systemic 
infections Dectin-1-deficient mice were in fact susceptible to localized GI tract colonization, correlated 
to increased fungal burdens, dysregulated cytokine responses and increased levels of bile acids. As a 
consequence, Dectin-1 might also be involved in controlling the colonization of gut mucosa by C. 
albicans following a previous oral infection. As mice are not colonized in a normal fashion by this 
fungal pathogen, similarly to the GI colonization experiment mice are treated with antibiotics to 
displace the endogenous microbiota and then orally infected with C. albicans via the drinking water 
[109]. Surprisingly, after oral infection, no difference in colonization levels of the Dectin-1−/− mice, was 
observed when compared to wild-type animals, neither in stool burdens nor in GI tissue fungal 
burdens. Moreover, Dectin-1 deficiency did not affect cytokine responses or tissue pathology during 
fungal GI colonization [61], revealing that Dectin-1 is not required for controlling mucosal 
colonization of the GI but it is fundamental for controlling systemic infection [61,110]. 
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4.4. Vagina 
Approximately 75% of all adult women are subject to vulvovaginal candidiasis at least once in their 
lives, and approximately half of these cases are re-infected with a rate of 5%–8% resulting in recurrent 
vulvovaginal candidiasis [111]. This indicates that some women are more prone to vaginal candidiasis. 
Dectin-1 Y238X polymorphism was initially correlated to individual predisposition causing Candida 
colonization and candidemia in 142 patients, who had a hematological malignancy [112]. The 
relationship between recurrent vulvovaginal candidiasis and Dectin-1 Y238X polymorphism was 
recently investigated [113] in 100 patients. Among them one individual had homozygous Dectin-1 
polymorphism and 13 individuals had heterozygous Dectin-1 polymorphism. This frequency could be 
defined as a polymorphism, however, the authors were not able to correlate the presence of Dectin-1 
Y238X polymorphism with recurrent vulvovaginal candidiasis etiology [113]. This preliminary result 
suggests a potential absence of Dectin-1 requirement in vaginal mucosa defense. However, the analysis 
was restricted to only a single polymorphism in Dectin-1 gene, thus limiting any definitive conclusion. 
It has been shown that during Candida vaginal infection, and in general mucosal candidiasis, 
Dectin-1 crucially contributes to the balance of Th1/Th17/Treg responses. However, the contribution 
of Dectin-1 mediated response is dependent on the genetic background of the host. In particular, 
different mice respond differently to mucosal candidiasis, in a manner dependent on Dectin-1 isoforms 
expression [114]. Macrophages from BALB/c mice express similar levels of the full-lenght Dectin-1A 
and the stalkless dectin-1B, while C57BL/6 derived macrophages predominantly express the smaller 
isoform [115]. This determines a different outcome in resistance and protection to the invading 
Candida, where BALB/c mice showed more resistance to re-infection. Dectin-1 deficiency 
disproportionally increases the Th17 cell-mediated response in C57BL/6 mice and the Th1/Treg 
balance in BALB/c mice. This last finding indicates that Dectin-1 signaling pathway could be involved 
in both Th1 and Th17 priming. 
5. Conclusion 
The shift between commensalism and pathogenicity is a combination of failure of host defenses and 
increased expression of specific virulence traits that promote establishment and progression of 
infection. The main driver of differential pathogenicity of different C. albicans strains seems to rely on 
the rapidity of the morphological switch and the resulting ability to evade immune defenses of the host. 
Especially, the different recognition of yeast and hyphae cells by the immune system prevents the 
drawing of a conclusive recognition model. Even though significant advancements regarding the 
molecular mechanisms underlying the morphological transition and the respective immune sensing, 
have been achieved in the last decade, those achievements are far from being conclusive and complete. 
This is mainly caused by contradictory reports to the prevailing view that yeast cells, but not C. 
albicans hyphae, trigger cytokine stimulation by human PBMCs and macrophages [116–118]. Here, 
new studies revealed that in contrast hyphae, but not yeast cells, stimulate macrophages’ production of 
IL-1β via the Nlrp3 inflammasome [98,119], a protective Th17 response [119], and an innate response 
in oral and vaginal epithelial cells [90,101]. 
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Additionally, the failure of murine studies in unequivocally showing the role of Dectin-1 and Th17 
response during systemic and mucosal Candida infection reveals (1) the possible involvement of 
different CLRs, (e.g., Dectin-2, Dectin-3); (2) how the confounding results obtained by using different 
models could rely on the site-specific requirements of peculiar cells to properly cope with the diverse 
Candida morphotypes; (3) how immune outcomes can be influenced by the strains used as infection agent. 
Several studies are suggesting that variability in fungal immune reactivity could depend on cell wall 
composition. This cell wall plasticity reflects the different ability of strains to face hostile 
environmental conditions, including temperature, pH and carbon source availability. 
Thus, we believe that the main future discoveries will stem from the investigation of the 
evolvability and ability of C. albicans to adapt to rapidly changing environments and to colonize 
diverse host microniches. The availability of a C. albicans deletion collection and of a large number of 
clinical isolates make Candida a perfect model to study the boundary between commensalism and 
pathogenicity, as a continuum between optimal recognition and host immune escape. In this respect, 
comparative population immunology studies should be addressed at understanding whether the ability 
of the immune system to discriminate between commensals and colonizers is specific or subtends a 
common scheme that can be applied to other less investigated pathogenic Candida species. 
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